I agree that this site is using cookies. You can find further informations here.
X
Liloglou, T.
132  results:
Search for persons X
?
1

P613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANIS..:

Kennedy, E. ; Mitchell, S. ; Burley, T. A....
HemaSphere.  6 (2022)  - p. 512-513 , 2022
Link: https://doi.org/10.1097/..
 
?
2

Epigenetic Reprogramming in Oral Epithelial Dysplasia using..:

McCarthy, CE ; Liloglou, T ; Hunter, K.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.  132 (2021)  1 - p. e28 , 2021
Link: https://doi.org/10.1016/..
 
?
3

A compelling argument for routine use of RNAScope in oropha..:

Schache, A. ; Risk, J.M. ; Liloglou, T....
British Journal of Oral and Maxillofacial Surgery.  50 (2012)  - p. S34 , 2012
Link: https://doi.org/10.1016/..
 
?
4

Does human papillomavirus 16 (HPV16) have a role in maligna..:

Schache, A. ; Matthews, A. ; Newey, C....
British Journal of Oral and Maxillofacial Surgery.  49 (2011)  - p. S12 , 2011
Link: https://doi.org/10.1016/..
 
?
5

Defining a prognostic biomarker in HPV-positive oropharynge..:

Schache, A. ; Robinson, M. ; Risk, J.M...
British Journal of Oral and Maxillofacial Surgery.  49 (2011)  - p. S11-S12 , 2011
Link: https://doi.org/10.1016/..
 
?
6

17 Novel epigenetic biomarkers of minimal residual disease ..:

Hobkirk, A.J. ; Nikolaidis, G. ; Liloglou, T...
British Journal of Oral and Maxillofacial Surgery.  48 (2010)  - p. S5 , 2010
Link: https://doi.org/10.1016/..
 
?
7

7 A clinically relevant biomarker in HPV related oropharyng..:

Schache, A. ; Filia, A. ; Wright, L....
British Journal of Oral and Maxillofacial Surgery.  48 (2010)  - p. S2 , 2010
Link: https://doi.org/10.1016/..
 
?
8

77 Predictive biomarkers for malignant transformation to ca..:

Schache, A. ; Shaw, R. ; Risk, J....
British Journal of Oral and Maxillofacial Surgery.  48 (2010)  - p. S20-S21 , 2010
Link: https://doi.org/10.1016/..
 
?
9

Colorectal adenomas with a low frequency of ki‐ras mutation..:

Kornaros, S. ; Liloglou, T. ; Politou, M..
Colorectal Disease.  7 (2005)  4 - p. 323-326 , 2005
Link: https://doi.org/10.1111/..
 
?
10

P-078 Abnormal CYGB expression and hypermethylation in non-..:

Liloglou, T. ; McRonald, F. ; Xinarianos, G....
Lung Cancer.  49 (2005)  - p. S134 , 2005
Link: https://doi.org/10.1016/..
 
?
11

O-045 Promotor-methylation profiling in lung cancer using M..:

Ehrich, M. ; Liloglou, T. ; Field, J...
Lung Cancer.  49 (2005)  - p. S18 , 2005
Link: https://doi.org/10.1016/..
 
?
12

Absence of association with cancer risk and low frequency o..:

Gorgoulis, V.G. ; Liloglou, T. ; Sigala, F....
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.  556 (2004)  1-2 - p. 143-150 , 2004
Link: https://doi.org/10.1016/..
 
?
13

Session 7:

Field, J.K. ; Heighway, J. ; Smith, S....
European Journal of Cancer Supplements.  2 (2004)  1 - p. 21 , 2004
Link: https://doi.org/10.1016/..
 
?
14

Absence of mutations in the VHL gene but frequent loss of h..:

Miyakis, S ; Liloglou, T ; Kearney, S...
Lung Cancer.  39 (2003)  3 - p. 273-277 , 2003
Link: https://doi.org/10.1016/..
 
?
15

Mutational analysis of CDKN2A genes in patients with squamo..:

Saridaki, Z. ; Liloglou, T. ; Zafiropoulos, A....
British Journal of Dermatology.  148 (2003)  4 - p. 638-648 , 2003
Link: https://doi.org/10.1046/..
 
1-15